Clinical Trial Update: Phase 1 Study to Evaluate the Safety, Tolerability, PK, and PD of TVB-3567 in Healthy Participants With or Without Acne [Phase 1]

View source ↗

Summary

A Phase 1 trial to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of TVB-3567 in healthy participants with or without acne is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• TVB-3567

Snippet

Sponsor: Sagimet Biosciences Inc. | Conditions: Acne | Phase 1 | Status: RECRUITING